Search results for " interventions."

showing 10 items of 248 documents

Associations of ofatumumab exposure and treatment outcomes in patients with untreated CLL receiving chemoimmunotherapy

2016

Relationships between patient characteristics, ofatumumab pharmacokinetics, and treatment outcomes were investigated in this phase 2 trial of ofatumumab plus fludarabine and cyclophosphamide (FC) in untreated chronic lymphocytic leukemia. Patients were randomized 1:1 to receive 500 or 1000 mg ofatumumab (Cycle 1; 300 mg) plus FC every 4 weeks for six cycles. Median C(max) and C(trough) values were similar at Cycle 1 regardless of the ultimate clinical outcome. At later doses, these values were higher for patients with complete response (CR) than for other patients. Higher C(max) and C(trough) values at Cycles 3 and 6 were significantly associated with an increased likelihood of CR, whereas …

OncologyMaleCancer ResearchLymphomaDrug ResistanceMedizinKaplan-Meier EstimatePharmacologychemistry.chemical_compound0302 clinical medicineAntineoplastic Agents ImmunologicalRecurrencehemic and lymphatic diseasesAntineoplastic Combined Chemotherapy Protocols80 and overChronicNeoplasm MetastasisLenalidomideCancerAged 80 and overUnivariate analysisLeukemiaRemission InductionAntibodies MonoclonalHematologyphase IIMiddle AgedLymphocyticThalidomideFludarabineClinical trialTreatment OutcomeOncologyTolerability6.1 Pharmaceuticals030220 oncology & carcinogenesisRetreatmentMathematikRituximabFemalePatient SafetyRefractory Chronic Lymphocytic LeukemiaUntreated Chronic Lymphocytic Leukemiamedicine.drugAdultmedicine.medical_specialtyCyclophosphamidelenalidomideClinical Trials and Supportive ActivitiesClinical SciencesImmunologyCmaxAntineoplastic AgentsNeutropeniaOfatumumabAntibodies Monoclonal HumanizedDrug Administration ScheduleArticle03 medical and health sciencesRare DiseasesClinical ResearchChemoimmunotherapyInternal medicinemedicineImmunologic FactorsAnimalsHumansIn patientAdverse effectLenalidomideAgedNeoplasm StagingChromosome Aberrationsbusiness.industryB-CellEvaluation of treatments and therapeutic interventionsmedicine.diseaseHaresLeukemia Lymphocytic Chronic B-CellDiscontinuationClinical trialchemistryDrug Resistance NeoplasmNeoplasmbusinessCLL030215 immunology
researchProduct

Phase III Trial of Avelumab Maintenance After First-Line Induction Chemotherapy Versus Continuation of Chemotherapy in Patients With Gastric Cancers:…

2021

PURPOSE The role of maintenance therapy for gastric (GC) or gastroesophageal junction cancer (GEJC) is unclear. We investigated avelumab (anti–programmed death ligand-1 [PD-L1]) maintenance after first-line induction chemotherapy for GC/GEJC. PATIENTS AND METHODS JAVELIN Gastric 100 was a global, open-label, phase III trial. Eligible patients had untreated, unresectable, human epidermal growth factor receptor 2–negative, locally advanced or metastatic GC or GEJC. Patients without progressive disease after 12 weeks of first-line chemotherapy with oxaliplatin plus a fluoropyrimidine were randomly assigned 1:1 to avelumab 10 mg/kg every 2 weeks or continued chemotherapy, stratified by region (…

OncologyMaleCancer Researchmedicine.medical_treatmentAvelumab0302 clinical medicineMaintenance therapyMonoclonalAntineoplastic Combined Chemotherapy Protocols030212 general & internal medicineMulticenterHumanizedCancerbiologyInduction ChemotherapyMiddle AgedPrognosisOxaliplatinSurvival RateOncology6.1 Pharmaceuticals030220 oncology & carcinogenesisFemaleFluorouracilmedicine.drugDouble-Blindmedicine.medical_specialtyFirst lineClinical Trials and Supportive ActivitiesClinical SciencesOncology and CarcinogenesisAntibodies Monoclonal HumanizedAntibodiesMaintenance Chemotherapy03 medical and health sciencesRare DiseasesClinical ResearchJavelinStomach NeoplasmsInternal medicinemedicineHumansIn patientOncology & CarcinogenesisCapecitabineAgedChemotherapybusiness.industryEvaluation of treatments and therapeutic interventionsInduction chemotherapyCancerbiology.organism_classificationmedicine.diseaseOpen-LabelTherapyCisplatinbusinessFollow-Up StudiesJournal of clinical oncology : official journal of the American Society of Clinical Oncology
researchProduct

Confirmation of TNIP1 but not RHOB and PSORS1C1 as systemic sclerosis risk factors in a large independent replication study

2012

Item does not contain fulltext INTRODUCTION: A recent genome-wide association study in European systemic sclerosis (SSc) patients identified three loci (PSORS1C1, TNIP1 and RHOB) as novel genetic risk factors for the disease. The aim of this study was to replicate the previously mentioned findings in a large multicentre independent SSc cohort of Caucasian ancestry. METHODS: 4389 SSc patients and 7611 healthy controls from different European countries and the USA were included in the study. Six single nucleotide polymorphisms (SNP): rs342070, rs13021401 (RHOB), rs2233287, rs4958881, rs3792783 (TNIP1) and rs3130573 (PSORS1C1) were analysed. Overall significance was calculated by pooled analys…

Oncologymedicine.medical_specialtysystemic sclerosisRHOBImmunologyGenome-wide association studySingle-nucleotide polymorphismBioinformaticsPolymorphism Single NucleotideGeneral Biochemistry Genetics and Molecular BiologyArticleWhite PeopleRheumatologyRisk FactorsInternal medicineRhoB GTP-Binding Proteinsystemic sclerosis; genome wide screening; genetic risk factorsmedicinegenetic risk factorsImmunology and AllergySNPHumansGenetic Predisposition to DiseaseAllelerhoB GTP-Binding ProteinRheumatology and AutoimmunityScleroderma Systemicbusiness.industryHaplotypeProteinsgenome wide screeningDNA-Binding ProteinsEuropeHaplotypesCohortEvaluation of complex medical interventions Auto-immunity transplantation and immunotherapy [NCEBP 2]businessGenome-Wide Association Study
researchProduct

Distribution of maternity units and spatial access to specialised care for women delivering before 32 weeks of gestation in Europe

2010

Contains fulltext : 88841.pdf (Publisher’s version ) (Closed access) Survival and quality of life are improved for very preterm babies when delivery occurs in a maternity unit with on-site neonatal intensive care (level III unit). We investigated the impact of distance on the probability of delivering in such a unit for births before 32 weeks of gestation from 9 European regions with diverse perinatal health systems (the MOSAIC cohort). We analysed distances between women's homes, and the nearest level III in population quartiles, adjusting for maternal and pregnancy characteristics. Living farther away from a level III reduced access to specialised care everywhere; in some regions women re…

Pediatricsmedicine.medical_specialtyHealth (social science)Perinatal careGeography Planning and DevelopmentPopulation[ SHS.GEO ] Humanities and Social Sciences/Geography03 medical and health sciences0302 clinical medicineQuality of life (healthcare)Hospital planningPregnancy030225 pediatricsIntensive caremedicineHumansMaternal Health Services030212 general & internal medicineeducationComputingMilieux_MISCELLANEOUSPregnancyeducation.field_of_study[SHS.SOCIO]Humanities and Social Sciences/SociologyDistancebusiness.industryHealth services accessibilityPublic Health Environmental and Occupational HealthInfant Newborn[ SHS.SOCIO ] Humanities and Social Sciences/Sociology[SHS.GEO]Humanities and Social Sciences/Geographymedicine.disease3. Good healthEuropeLogistic ModelsQuartileEvaluation of complex medical interventions [NCEBP 2]Premature birthdistance; europe; health services accessibility; hospital planning; perinatal careCohortMultivariate AnalysisGestationPremature BirthFemale[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologieHuman medicinebusinessDemography
researchProduct

Resultados de un programa de educación postural, con una intervención gamificada vs intervención tradicional

2021

[Resumen] La metodología de enseñanza adoptada por el profesorado puede influir en los niveles de participación y aprendizaje del alumnado. El objetivo principal de este estudio fue comparar el efecto de dos programas de intervención de educación postural en función de la metodología utilizada. Un total de 36 estudiantes (19 niñas y 17 niños) de 1º de Educación Secundaria Obligatoria participaron en el estudio. En el primer programa de intervención se aplicó una metodología gamificada, mientras que en el segundo se empleó una metodología tradicional. Ambos programas de intervención se llevaron a cabo a lo largo de 6 sesiones. Se analizaron los contenidos teóricos a través de dos cuestionari…

Physical Education (secon dary)Posturamedia_common.quotation_subjectTeaching methodApplied psychologyPosturePhysical education (secondary)Session (web analytics)03 medical and health sciences0302 clinical medicinePerceptionIntervention (counseling)030212 general & internal medicineEducación físicamedia_commonEducación para la saludMotivation030229 sport sciencesGeneral MedicineGamificationTest (assessment)GamificaciónFeelingHealth educationScale (social sciences)MotivaciónEducational interventionsPsychology
researchProduct

Redox Regulation of Metabolic Syndrome: From Biochemical Mechanisms to Nutritional Interventions.

2021

According to its “harmonized” definition, metabolic syndrome (MetS) is described as a cluster of metabolic factors that increases the risk of cardiovascular diseases, diabetes (DM) and associated morbidities such as dementia [...]

Physiologybusiness.industryClinical BiochemistryMEDLINECell BiologyRM1-950medicine.diseaseBioinformaticsDisease clusterBiochemistrymetabolic syndromeredox regulationn/aEditorialNutritional InterventionsDiabetes mellitusmental disordersmedicineDementiaTherapeutics. PharmacologyMetabolic syndromebusinessMolecular BiologyAntioxidants (Basel, Switzerland)
researchProduct

Catheter venography for the assessment of internal jugular veins and azygous vein: position statement by expert panel of the International Society fo…

2013

This document by an expert panel of the International Society for Neurovascular Disease is aimed at presenting current technique and interpretation of catheter venography of the internal jugular veins, azygous vein and other veins draining the central nervous system. Although interventionalists agree on general rules, significant differences exist in terms of details of venographic technique and interpretations of angiographic pictures. It is also suggested that debatable findings should be investigated using multimodal diagnostics. Finally, the authors recommend that any publication on chronic cerebrospinal venous insufficiency should include detailed description of venographic technique u…

Position statementmedicine.medical_specialtyCatheterization Central VenousEndovascular therapyVenographyConstriction Pathologicmultiple sclerosisRisk Assessmentneurovascular interventionsPredictive Value of TestsmedicineHumansVascular Diseasesvascular malformationsUltrasonography Interventionalmedicine.diagnostic_testbusiness.industryPhlebographyNeurovascular bundlemedicine.diseasePrognosisCerebral VeinsCatheterAzygous veinChronic cerebrospinal venous insufficiencyCerebrovascular DisordersChronic diseaseVenous InsufficiencyAzygos VeinChronic Diseasecardiovascular systemRadiologyUltrasonographyJugular VeinsCardiology and Cardiovascular MedicinebusinessVASA. Zeitschrift fur Gefasskrankheiten
researchProduct

BBS1 Mutations in a Wide Spectrum of Phenotypes Ranging From Nonsyndromic Retinitis Pigmentosa to Bardet-Biedl Syndrome

2012

OBJECTIVE: To investigate the involvement of the Bardet-Biedl syndrome (BBS) gene BBS1 p.M390R variant in nonsyndromic autosomal recessive retinitis pigmentosa (RP). METHODS: Homozygosity mapping of a patient with isolated RP was followed by BBS1 sequence analysis. We performed restriction fragment length polymorphism analysis of the p.M390R allele in 2007 patients with isolated RP or autosomal recessive RP and in 1824 ethnically matched controls. Patients with 2 BBS1 variants underwent extensive clinical and ophthalmologic assessment. RESULTS: In an RP proband who did not fulfill the clinical criteria for BBS, we identified a large homozygous region encompassing the BBS1 gene, which carrie…

ProbandMaleBBS1Genetics and epigenetic pathways of disease [NCMLS 6]DNA Mutational AnalysisEvaluation of complex medical interventions Genomic disorders and inherited multi-system disorders [NCEBP 2]GenotypeEthnicityPrevalenceIsraelGeneticseducation.field_of_studyRetinitis Pigmentosa/diagnosisMiddle AgedDisease gene identificationPedigreeEuropePhenotypeFemaleMicrotubule-Associated ProteinsRetinitis PigmentosaAdultcongenital hereditary and neonatal diseases and abnormalitiesCanadaPopulationCanada/epidemiologyMicroscopy AcousticMutation MissenseEthnic GroupsDNA/geneticsBiologyEurope/epidemiologyGenomic disorders and inherited multi-system disorders [IGMD 3]Bardet-Biedl Syndrome/diagnosisBardet–Biedl syndromeRetinitis pigmentosamedicineElectroretinographyHumansAlleleeducationBardet-Biedl SyndromeIsrael/epidemiologyAllelesDNAMicrotubule-Associated Proteins/geneticsmedicine.diseaseOphthalmoscopyOphthalmologyGenetics and epigenetic pathways of disease Genomic disorders and inherited multi-system disorders [NCMLS 6]
researchProduct

Pharmacological interventions for people with histrionic personality disorder

2011

Reason for withdrawal from publication Authors have made no progress with this protocol in over a year due to difficulties with identifying potentially suitable studies. The protocol has been withdrawn. To view the published versions of this article, please click the 'Other versions' tab.

Protocol (science)Pharmacological interventionsHistrionic personality disordermedicinePsychologymedicine.diseaseClinical psychology
researchProduct

Pharmacological interventions for people with narcissistic personality disorder

2011

Reason for withdrawal from publication Authors have made no progress with this protocol in over two years due to difficulties with identifying potentially suitable studies. The protocol has been withdrawn. To view the published versions of this article, please click the 'Other versions' tab.

Protocol (science)Pharmacological interventionsPsychotherapistbusiness.industryNarcissistic personality disorderMedicinebusinessmedicine.disease
researchProduct